Single cell-based drug discovery with Greg Ryslik (Celsius Therapeutics)

In my conversation with Greg Ryslik, previously Chief Data Officer and now Special Adviser to Celsius Therapeutics, we talk about single cell sequencing technologies and the nuance they enable with respect to identifying and targeting the cell populations that are responsible for driving diseases, as well as the machine learning frameworks he employs when approaching problems with large-scale datasets.

Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary